Report Detail

Pharma & Healthcare Global Cognitive and Memory Enhancer Drugs Market Professional Survey Report 2019

  • RnM3785209
  • |
  • 26 September, 2019
  • |
  • Global
  • |
  • 107 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.
The major factors that drive the growth of the global cognitive and memory enhancer drugs market include surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning propel the market growth. However, ethical issues related to the use of these drugs restrict the market growth.

The global Cognitive and Memory Enhancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cognitive and Memory Enhancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cognitive and Memory Enhancer Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cognitive and Memory Enhancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cognitive and Memory Enhancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Eisai Co
Allergan
Novartis
Shire
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript
Cephalon
Ceretropic

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others

Segment by Application
Disease Treatment
Academic Performance
Athletic Performance
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Cognitive and Memory Enhancer Drugs

      • 1.1 Definition of Cognitive and Memory Enhancer Drugs
      • 1.2 Cognitive and Memory Enhancer Drugs Segment by Type
        • 1.2.1 Global Cognitive and Memory Enhancer Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Aricept
        • 1.2.3 Exelon
        • 1.2.4 Namenda
        • 1.2.5 Razadyne
        • 1.2.6 Provigil
        • 1.2.7 Ritalin
        • 1.2.8 Adderall
        • 1.2.9 Others
      • 1.3 Cognitive and Memory Enhancer Drugs Segment by Applications
        • 1.3.1 Global Cognitive and Memory Enhancer Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Disease Treatment
        • 1.3.3 Academic Performance
        • 1.3.4 Athletic Performance
        • 1.3.5 Others
      • 1.4 Global Cognitive and Memory Enhancer Drugs Overall Market
        • 1.4.1 Global Cognitive and Memory Enhancer Drugs Revenue (2014-2025)
        • 1.4.2 Global Cognitive and Memory Enhancer Drugs Production (2014-2025)
        • 1.4.3 North America Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Cognitive and Memory Enhancer Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cognitive and Memory Enhancer Drugs
      • 2.3 Manufacturing Process Analysis of Cognitive and Memory Enhancer Drugs
      • 2.4 Industry Chain Structure of Cognitive and Memory Enhancer Drugs

      3 Development and Manufacturing Plants Analysis of Cognitive and Memory Enhancer Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cognitive and Memory Enhancer Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cognitive and Memory Enhancer Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cognitive and Memory Enhancer Drugs Production and Capacity Analysis
      • 4.2 Cognitive and Memory Enhancer Drugs Revenue Analysis
      • 4.3 Cognitive and Memory Enhancer Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Cognitive and Memory Enhancer Drugs Regional Market Analysis

      • 5.1 Cognitive and Memory Enhancer Drugs Production by Regions
        • 5.1.1 Global Cognitive and Memory Enhancer Drugs Production by Regions
        • 5.1.2 Global Cognitive and Memory Enhancer Drugs Revenue by Regions
      • 5.2 Cognitive and Memory Enhancer Drugs Consumption by Regions
      • 5.3 North America Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.3.1 North America Cognitive and Memory Enhancer Drugs Production
        • 5.3.2 North America Cognitive and Memory Enhancer Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cognitive and Memory Enhancer Drugs Import and Export
      • 5.4 Europe Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.4.1 Europe Cognitive and Memory Enhancer Drugs Production
        • 5.4.2 Europe Cognitive and Memory Enhancer Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cognitive and Memory Enhancer Drugs Import and Export
      • 5.5 China Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.5.1 China Cognitive and Memory Enhancer Drugs Production
        • 5.5.2 China Cognitive and Memory Enhancer Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cognitive and Memory Enhancer Drugs Import and Export
      • 5.6 Japan Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.6.1 Japan Cognitive and Memory Enhancer Drugs Production
        • 5.6.2 Japan Cognitive and Memory Enhancer Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cognitive and Memory Enhancer Drugs Import and Export
      • 5.7 Southeast Asia Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.7.1 Southeast Asia Cognitive and Memory Enhancer Drugs Production
        • 5.7.2 Southeast Asia Cognitive and Memory Enhancer Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cognitive and Memory Enhancer Drugs Import and Export
      • 5.8 India Cognitive and Memory Enhancer Drugs Market Analysis
        • 5.8.1 India Cognitive and Memory Enhancer Drugs Production
        • 5.8.2 India Cognitive and Memory Enhancer Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cognitive and Memory Enhancer Drugs Import and Export

      6 Cognitive and Memory Enhancer Drugs Segment Market Analysis (by Type)

      • 6.1 Global Cognitive and Memory Enhancer Drugs Production by Type
      • 6.2 Global Cognitive and Memory Enhancer Drugs Revenue by Type
      • 6.3 Cognitive and Memory Enhancer Drugs Price by Type

      7 Cognitive and Memory Enhancer Drugs Segment Market Analysis (by Application)

      • 7.1 Global Cognitive and Memory Enhancer Drugs Consumption by Application
      • 7.2 Global Cognitive and Memory Enhancer Drugs Consumption Market Share by Application (2014-2019)

      8 Cognitive and Memory Enhancer Drugs Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Eisai Co
        • 8.2.1 Eisai Co Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.2.2 Eisai Co Product Introduction, Application and Specification
        • 8.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Allergan
        • 8.3.1 Allergan Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.3.2 Allergan Product Introduction, Application and Specification
        • 8.3.3 Allergan Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Shire
        • 8.5.1 Shire Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.5.2 Shire Product Introduction, Application and Specification
        • 8.5.3 Shire Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson & Johnson
        • 8.6.1 Johnson & Johnson Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Takeda Pharmaceutical Company Limited
        • 8.7.1 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.7.2 Takeda Pharmaceutical Company Limited Product Introduction, Application and Specification
        • 8.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 AlternaScript
        • 8.8.1 AlternaScript Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.8.2 AlternaScript Product Introduction, Application and Specification
        • 8.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Cephalon
        • 8.9.1 Cephalon Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.9.2 Cephalon Product Introduction, Application and Specification
        • 8.9.3 Cephalon Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Ceretropic
        • 8.10.1 Ceretropic Cognitive and Memory Enhancer Drugs Production Sites and Area Served
        • 8.10.2 Ceretropic Product Introduction, Application and Specification
        • 8.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Cognitive and Memory Enhancer Drugs Market

      • 9.1 Global Cognitive and Memory Enhancer Drugs Market Trend Analysis
        • 9.1.1 Global Cognitive and Memory Enhancer Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cognitive and Memory Enhancer Drugs Regional Market Trend
        • 9.2.1 North America Cognitive and Memory Enhancer Drugs Forecast 2019-2025
        • 9.2.2 Europe Cognitive and Memory Enhancer Drugs Forecast 2019-2025
        • 9.2.3 China Cognitive and Memory Enhancer Drugs Forecast 2019-2025
        • 9.2.4 Japan Cognitive and Memory Enhancer Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Cognitive and Memory Enhancer Drugs Forecast 2019-2025
        • 9.2.6 India Cognitive and Memory Enhancer Drugs Forecast 2019-2025
      • 9.3 Cognitive and Memory Enhancer Drugs Market Trend (Product Type)
      • 9.4 Cognitive and Memory Enhancer Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cognitive and Memory Enhancer Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Cognitive and Memory Enhancer Drugs. Industry analysis & Market Report on Cognitive and Memory Enhancer Drugs is a syndicated market report, published as Global Cognitive and Memory Enhancer Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cognitive and Memory Enhancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,751.00
        4,126.50
        5,502.00
        3,234.00
        4,851.00
        6,468.00
        548,030.00
        822,045.00
        1,096,060.00
        291,515.00
        437,272.50
        583,030.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report